{
    "organizations": [],
    "uuid": "6922d7bf426bc5d5f6ededc33fa4829d95bf12eb",
    "author": "",
    "url": "https://www.reuters.com/article/brief-fda-accepts-remoxy-nda-for-reviews/brief-fda-accepts-remoxy-nda-for-reviewsets-pdufa-date-of-aug-7-2018-idUSASB0C8B5",
    "ord_in_thread": 0,
    "title": "BRIEF-FDA Accepts Remoxy NDA For Review, Sets PDUFA Date Of Aug 7, 2018",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 1, 2018 / 1:22 PM / in 10 minutes BRIEF-FDA Accepts Remoxy NDA For Review, Sets PDUFA Date Of Aug 7, 2018 Reuters Staff March 1 (Reuters) - Pain Therapeutics Inc: * FDA ACCEPTS REMOXYÂ® NDA FOR REVIEW, SETS PDUFA DATE OF AUGUST 7, 2018 * U.S. FDA DETERMINED THAT A NDA FOR REMOXY ER IS SUFFICIENTLY COMPLETE TO PERMIT A SUBSTANTIVE REVIEW * FDA HAS SET AN ACTION DATE OF AUGUST 7, 2018 UNDER PRESCRIPTION DRUG USER FEE ACT (PDUFA) * PAIN THERAPEUTICS -BELIEVES FDA WILL HOLD AN OPEN ADVISORY COMMITTEE MEETING TO DISCUSS REMOXY ER, ALTHOUGH A DATE HAS NOT YET BEEN DETERMINED. Source text for Eikon: Further company coverage:",
    "published": "2018-03-01T15:21:00.000+02:00",
    "crawled": "2018-03-01T15:42:34.037+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "minute",
        "accepts",
        "remoxy",
        "nda",
        "review",
        "set",
        "pdufa",
        "date",
        "aug",
        "reuters",
        "staff",
        "march",
        "reuters",
        "pain",
        "therapeutic",
        "inc",
        "fda",
        "accepts",
        "nda",
        "review",
        "set",
        "pdufa",
        "date",
        "august",
        "fda",
        "determined",
        "nda",
        "remoxy",
        "er",
        "sufficiently",
        "complete",
        "permit",
        "substantive",
        "review",
        "fda",
        "set",
        "action",
        "date",
        "august",
        "prescription",
        "drug",
        "user",
        "fee",
        "act",
        "pdufa",
        "pain",
        "therapeutic",
        "fda",
        "hold",
        "open",
        "advisory",
        "committee",
        "meeting",
        "discus",
        "remoxy",
        "er",
        "although",
        "date",
        "yet",
        "determined",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}